Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Bioadaptives (BDPT) Shares Outstanding (Diluted Average) (2019 - 2025)

Bioadaptives' Shares Outstanding (Diluted Average) history spans 4 years, with the latest figure at $10.1 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 22.61% to $10.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $10.1 million, a 22.61% increase, with the full-year FY2025 number at $10.1 million, up 22.61% from a year prior.
  • Shares Outstanding (Diluted Average) hit $10.1 million in Q4 2025 for Bioadaptives, up from $9.4 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for BDPT hit a ceiling of $10.1 million in Q4 2025 and a floor of $3.7 million in Q2 2024.